- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 419.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 422.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 448M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $606M |
| Stock Repurchased | Q1 2026 · Dec 31, 2025 | $1.54B |
| Stock Repurchased | Q1 2026 · Dec 18, 2025 | $248M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $443M |
| Capex | Q1 2026 · Mar 31, 2026 | $110M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $178M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $401M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $515M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $9.05B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $9.04B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.94B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.45B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.23B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.42B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.05B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.17B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.92B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.08B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.47B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.77B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $15.15B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $15.49B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.42 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $1.34 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.42 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $1.34 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $588M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $574M |
| Net Income | Q1 2026 · Mar 31, 2026 | $601M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $602M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $641M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $618M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.26B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $2.2B |